Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Two More China Drug Makers Said To Have Used 'Gutter Oil' In Antibiotics

This article was originally published in PharmAsia News

Executive Summary

Qilu Pharmaceutical and Charoen Pokphand Group have been named as two additional China drug makers involved in a scandal of using restaurant-disposed cooking oil in production of antibiotics.

Qilu Pharmaceutical and Charoen Pokphand Group have been named as two additional China drug makers involved in a scandal of using restaurant-disposed cooking oil in production of antibiotics. An analyst said continuing growth in the scandal could greatly damage the image of the nation's pharmaceutical industry. Joincare Pharmaceutical Group already is under investigation, and Henan Huikang has been identified as the supplier of the contaminated oil to the drug companies. Qilu said it was not aware it was receiving adulterated oil, and CP Group said it has severed connections with the supplier. (Click here for more)

"Gutter Oil Drug Scandal Widens" - Global Times (China) (9/4/2012)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC082317

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel